Wiener klinische Wochenschrift

, Volume 122, Supplement 2, pp 19–25

Autoantibodies pANCA, GAB and PAB in inflammatory bowel disease: prevalence, characteristics and diagnostic value

  • Evgenija Homšak
  • Dušanka Mičetić-Turk
  • Borut Božič
Original article


BACKGROUND: The diagnosis of inflammatory bowel disease (IBD), particularly the differentiation between ulcerative colitis (UC) and Crohn's disease (CD), is difficult and delayed in many cases, despite invasive diagnostic tools. AIMS: To determine the presence and evaluate the diagnostic accuracy of the potential serological diagnostic markers perinuclear antineutrophil cytoplasmic antibodies (pANCA), autoantibodies to intestinal goblet cells (GAB) and autoantibodies to exocrine pancreas (PAB), together with combinations of these, in the diagnosis of IBD and differential diagnosis of UC and CD. METHODS: The presence of pANCA, GAB and PAB was determined in indirect immunofluorescence assay of serum samples from 71 patients with IBD (CD 43, UC 28) and 41 healthy controls. The antigen specificity of ANCA was determined using ELISA. RESULTS: Compared with the control group, we confirmed a statistically significant presence of pANCA (71.4%) and GAB (46.4%) in patients with UC and the presence of PAB only in patients with CD (30.2%) (P < 0.001). In healthy controls, neither PAB nor GAB was detected and pANCA was present in only 4.8%. The sensitivity, specificity and positive and negative predictive values in differentiation of IBD from healthy controls were as follows: pANCA+: 71%, 95%, 91%, 83%; GAB+: 46%, 100%, 100%, 73%; PAB+: 30%, 100%, 100%, 58%; combination of (pANCA+ or GAB+)/PAB: 82%, 95%, 92%, 87%; and to distinguish UC from CD: pANCA+: 71%, 98%, 95%, 84%; GAB+: 46%, 98%, 93%, 74%; PAB+: 30%, 100%, 100%, 48%; (pANCA+ or GAB+)/PAB: 82%, 98%, 96%, 89%. CONCLUSIONS: All three autoantibodies may be helpful tools in non-invasive diagnosis and differential diagnosis of UC and CD. Combination of the autoantibodies may be particularly helpful, as the diagnostic sensitivity is considerably improved.


Inflammatory bowel disease Autoimmunity Autoantibodies Diagnostic markers Diagnostic value 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Glickman RM (1980) Inflammatory bowel disease. In: Isselbacher KJ, Adams RD, Braunwald E, Petersdorf RG, Wilson JD (eds) Harrison's principles of internal medicine, 9th edn. McGraw-Hill, New York, pp 1403–11Google Scholar
  2. Kirschner BS (1995) Ulcerative colitis and Crohn's disease in children. Diagnosis and management. Ped Gastroenterol II 24: 99–117Google Scholar
  3. Sanders DSA (1996) The differential diagnosis of Crohn's disease and ulcerative colitis. Baillière's Clin Gastroenterol 12: 19–33CrossRefGoogle Scholar
  4. Krause S, Meier R, Wegmann W, Spichtin H, Aenishänslin HW (1998) Difficulties in differentiating Crohn's disease and ulcerative colitis. Praxis 87: 1607–11PubMedGoogle Scholar
  5. Khulusi S, Rhodes J (1997) Diagnostic dilemmas in colitis. J Roy Coll Phys London 31: 618–23Google Scholar
  6. Cho JH, Brant SR (1998) Genetics and genetic markers in inflammatory bowel disease. Curr Opin Gastroenterol 14: 283–8CrossRefGoogle Scholar
  7. Koutrobakis I, Manousos ON, Mewwissen SGM, Pena AS (1996) Environmental risk factors in inflammatory bowel disease. Hepatogastroenterology 43: 381–93Google Scholar
  8. Fiocchi C (1998) Inflammatory bowel disease: etiology and pathogenesis. Gastroenterol 115: 182–205CrossRefGoogle Scholar
  9. Schölmerich J (1996) Autoimmune Erkrankungen des Magen-Darm-Trakts. In: Peter HH, Pichler WJ (eds) Klinische Immunologie, 2. Aufl. Urban & Schwarzenberg, München Wien Baltimore, pp 532–46Google Scholar
  10. Ginsburg CH, Ault KA, Falchuk ZM (1981) Monoclonal B lymphocytes in the peripheral blood of patients with inflammatory bowel disease. Gastroenterology 81: 1111–4PubMedGoogle Scholar
  11. Das KM (1999) Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis. Digestive Dis Sci 44: 1–13CrossRefGoogle Scholar
  12. Broberger O, Perlmann P (1959) Autoantibodies in human ulcerative colitis. J Exp Med 110: 657–74CrossRefPubMedGoogle Scholar
  13. Shanahan F (1992) The role of autoantibodies and autoimmunity in chronic inflammatory disorders of the gut. Curr Opin Gastroenterol 8: 988–92CrossRefGoogle Scholar
  14. Stevens TR, Harley SL, Groom JS, Cambridge G, Leaker B, Blake DR, et al (1993) Anti-endothelial cell antibodies in inflammatory bowel disease. Dig Dis Sci 38: 426–32CrossRefPubMedGoogle Scholar
  15. Das KM, Dasgupta A, Mandal A, Geng X (1993) Autoimmunity to cytoskeletal protein tropomyosin: a clue to the pathogenetic mechanism for ulcerative colitis. Immunology 150: 2487–93Google Scholar
  16. Abad E, Tueal C, Mirapeix E, Cuxart A (1997) Relationship between ANCA and clinical activity in inflammatory bowel disease: variation in prevalence of ANCA and evidence of heterogenity. J Autoimmun 10: 175–80CrossRefPubMedGoogle Scholar
  17. Terjung B, Herzog V, Worman HJ, Gestmann I, Bauer C, Sauerbruch T, et al (1998) Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins. Hepatology 28: 332–40CrossRefPubMedGoogle Scholar
  18. Stöcker W, Otte M, Ulrich S, Normann D, Stöcker K, Jantschek G (1984) Autoantikörper gegen exokrines Pankreas und gegen intestinale Becherzellen in der Diagnostik des Morbus Crohn und der Colitis ulcerosa. Dtsch Med Wschr 109: 1963–1969PubMedGoogle Scholar
  19. Hibi T, Ohara M, Kobayashi K, Brown WR, Toda K, Takaishi H, et al (1994) Enzyme linked immunosorbent assay (ELISA) and immunoprecipitation studies on anti-goblet cell antibody using a mucin producing cell line patients with inflammatory bowel disease. Gut 35: 224–30CrossRefPubMedGoogle Scholar
  20. Folwaczny C, Noehl N, Tschöp K, Endres SP, Heldwein W, Loeschke K, et al (1997) Goblet cell autoantibodies in patients with inflammatory bowel disease and their first-degree relatives. Gastroenterol 133: 101–6CrossRefGoogle Scholar
  21. Takaishi H, Ohara S, Hotta K, Yajima T, Kanai T, Inoue N, et al (2000) Circulating autoantibodies against purified colonic mucin in ulcerative colitis. J Gastroenterol 35: 20–7CrossRefPubMedGoogle Scholar
  22. Stöcker W, Otte M, Ulrich S, Normann D, Finkbeiner H, Stöcker K, et al (1987) Autoimmunity to pancreatic juice in Crohn's disease. J Gastroenterol 22[Suppl 139]: 41–52Google Scholar
  23. Sasse EA (1996) Reference intervals and clinical decision limits. In: Kaplan LA, Pesce AJ (eds) Clinical chemistry: theory, analysis, correlation, 3rd edn. Mosby-Year Book Inc., St Louis, pp 365–81Google Scholar
  24. Falk RJ, Jenette JC (1988) Antineutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and crescentic glomerulonephritis. N Engl J Med 318: 1651–7PubMedGoogle Scholar
  25. Peeters M, Joossens S, Vermeire SV, Vlietinck R, Bossuyt X, Rutgeerts P (2001) Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol 96: 730–4CrossRefPubMedGoogle Scholar
  26. Roozendaal C, Pogany K, Horst G, Jagt TG, Kleibeuker JH, Nelis GF, et al (1999) Does analysis of the antigenic specificities of anti-neutrophil cytoplasmic antibodies contribute to their clinical significance in the inflammatory bowel diseases? Scand J Gastroenterol 34: 1123–31CrossRefPubMedGoogle Scholar
  27. Radice A, Vecchi M, Bianchi MB, Sinico RA (2000) Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives. Clin Exp Rheumatol 18: 707–12PubMedGoogle Scholar
  28. Eggena M, Cohavy O, Parseghian MH, Hamkalo BA, Clemens D, Targan SR, et al (2000) Identification of histone H1 as a cognate antigen of the ulcerative colitis-associated marker antibody pANCA. J Autoimmun 14: 83–97CrossRefPubMedGoogle Scholar
  29. Sobajima J, Ozaki S, Osakada F, Uesugi H, Shirakawa H, Yoshida M, et al (1997) Novel autoantigens of perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis: non-histone chromosomal proteins, HMG1 and HMG2. Clin Exp Immunol 107: 135–40CrossRefPubMedGoogle Scholar
  30. Mallolas J, Esteve M, Rius E, Cabré E, Gassull MA (2000) Antineutrophil antibodies associated with ulcerative colitis interact with the antigen(s) during the process of apoptosis. Gut 47: 74–8CrossRefPubMedGoogle Scholar
  31. Wiik A (2002) Neutrophil-specific autoantibodies in chronic inflammatory bowel diseases. Autoimmun Rev 1: 67–72CrossRefPubMedGoogle Scholar
  32. Sobajima J, Ozaki S, Okazaki T, Osakada F, Sumita S, Mori K, et al (1996) Anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis: anti-cathepsin G and a novel antibody correlate with a refractory type. Clin Exp Immunol 105: 120–4CrossRefPubMedGoogle Scholar
  33. Yang P, Bohr J, Tysk C, Danielsson D, Järnerot G (1996) Antineutrophil cytoplasmic antibodies in inflammatory bowel disease and collagenous colitis: no association with lactoferrin, β-glucorinidase, myeloperoxidase, or proteinase 3. Inflamm Dis 2: 173–7CrossRefGoogle Scholar
  34. Kuwana T, Sato Y, Saka M, Kondo Y, Miyata M, Obara K, et al (2000) Anti-cathepsin G antibodies in the sera of patients with ulcerative colitis. J Gastroenterol 35: 682–9CrossRefPubMedGoogle Scholar
  35. Seibold F, Weber P, Jenss H, Wiedmann KH (1991) Antibodies to a trypsin sensitive pancreatic antigen in chronic inflammatory bowel disease: specific markers for a subgroup of patient with Crohn's disease. Gut 32: 1192–7CrossRefPubMedGoogle Scholar
  36. Goischke EM, Zilly W (1992) Klinische Bedeutung organspezifische Antikörper bei Colitis ulcerosa und Morbus Crohn. Z Gastroenterol 30: 319–24PubMedGoogle Scholar
  37. Seibold F, Mörk H, Tanza S, Müller, Holzhüter C, Weber P, et al (1997) Pancreatic autoantibodies in Crohn's disease: a family study. Gut 40: 481–4PubMedGoogle Scholar
  38. Quinton JF, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, et al (1998) Anti-Saccharomices cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 42: 788–91PubMedGoogle Scholar
  39. Ruemmele FM, Targan SR, Levy G, et al (1998) Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterol 115: 822–9CrossRefGoogle Scholar
  40. Dietrich W, Ehnis T, Bauer M, Donner P, Volta U, Ricken EO, et al (1997) Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 3: 797–801CrossRefGoogle Scholar
  41. Unger F (2008) Health is wealth – Toward a European lead market in health care. Acta Medico-Biotechnica 1: 11–8Google Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Evgenija Homšak
    • 1
    • 4
  • Dušanka Mičetić-Turk
    • 2
    • 4
  • Borut Božič
    • 3
  1. 1.Department of Laboratory DiagnosisUniversity Medical Center MariborMariborSlovenia
  2. 2.Department of PediatricsUniversity Medical Center MariborMariborSlovenia
  3. 3.Department of RheumatologyUniversity Medical CenterLjubljanaSlovenia
  4. 4.Faculty of MedicineUniversity of MariborMariborSlovenia

Personalised recommendations